Tag: Brazilian pharma

Insights

Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen

26 de May de 2026

The most comprehensive resource for portfolio managers and investors focused on emerging markets — with a special emphasis on Brazil. In-depth analysis, curated insights, and data-driven perspectives on Latin America’s largest economy.

Navigate

Home
About us
Insights
Compliance
Contact

Follow

X
Instagram
LinkedIn
Facebook

Tag: Brazilian pharma

Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen